Scott Armstrong, PhD, MD
Dana-Farber Cancer Institute
Dr. Armstrong is Chair of the Dept. of Pediatric Oncology and the David G. Nathan Professor of Pediatrics at the Dana-Farber Cancer Institute, Boston Children’s Hospital, and Harvard Medical School. He is also President of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. His research group has made seminal discoveries into leukemia biology and chromatin based epigenetic mechanisms in cancer spurring the development of several new classes of therapeutic agents that target epigenetic mechanisms and gene activity in cancer, many already being tested in clinical trials for children and adults. He has served on review committees for LLS and has served multiple roles for the American Association for Cancer Research including as a member of the Board of Directors. His work has been recognized with awards such as the Paul Marks Prize for Cancer Research from Memorial Sloan Kettering Cancer Center, the E. Mead Johnson Award from the Society for Pediatric Research and the Dameshek Prize from the American Society of Hematology. He is a member of the National Academy of Medicine.